
Sign up to save your podcasts
Or


In this episode of Beatwise The Podcast, I speak with Dr Archana Ganapathy about a problem we don’t talk about enough in heart failure: congestion that we can’t properly see.
Many patients leave hospital still fluid overloaded at a tissue level - despite looking “better” clinically. And that gap is part of why readmissions and outcomes remain poor. We discuss why current tools - from clinical exam to imaging and biomarkers - often fall short, and why understanding where fluid sits in the body matters just as much as how much is there.
We then explore bioimpedance: what it is, how it works at the bedside, and why it may offer a more objective way to guide treatment. Dr Ganapathy also shares early insights from the BioHF trial, including what happens when fluid management is guided by measurement rather than estimation.
For further context, Dr Ganapathy’s recent review on congestion assessment in decompensated heart failure is linked here: Advances in Congestion Assessment in Decompensated Heart Failure
Key issues addressed:
If you care for patients with heart failure - or live with it - this is worth understanding.
EPISODE HIGHLIGHTS:
00:00 Hidden congestion problem
02:00 Why assessment falls short
05:05 Fluid location matters
07:02 Promise of bioimpedance
08:54 How bioimpedance works
13:06 BioHF trial design
17:16 Early findings & future impact
22:29 Recruitment & next steps
23:06 Wrap up
If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.
Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!
Thank you to Maltron International Limited for sponsoring this episode.
Hosted on Acast. See acast.com/privacy for more information.
By Sarah BirkhoelzerIn this episode of Beatwise The Podcast, I speak with Dr Archana Ganapathy about a problem we don’t talk about enough in heart failure: congestion that we can’t properly see.
Many patients leave hospital still fluid overloaded at a tissue level - despite looking “better” clinically. And that gap is part of why readmissions and outcomes remain poor. We discuss why current tools - from clinical exam to imaging and biomarkers - often fall short, and why understanding where fluid sits in the body matters just as much as how much is there.
We then explore bioimpedance: what it is, how it works at the bedside, and why it may offer a more objective way to guide treatment. Dr Ganapathy also shares early insights from the BioHF trial, including what happens when fluid management is guided by measurement rather than estimation.
For further context, Dr Ganapathy’s recent review on congestion assessment in decompensated heart failure is linked here: Advances in Congestion Assessment in Decompensated Heart Failure
Key issues addressed:
If you care for patients with heart failure - or live with it - this is worth understanding.
EPISODE HIGHLIGHTS:
00:00 Hidden congestion problem
02:00 Why assessment falls short
05:05 Fluid location matters
07:02 Promise of bioimpedance
08:54 How bioimpedance works
13:06 BioHF trial design
17:16 Early findings & future impact
22:29 Recruitment & next steps
23:06 Wrap up
If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.
Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!
Thank you to Maltron International Limited for sponsoring this episode.
Hosted on Acast. See acast.com/privacy for more information.